You are here

Clinical Trials: Urological Disease

Each Clinical Trial will open in a new browser window or tab.

Return to Clinical Trials Page

Posted: Friday, January 6, 2017 - 12:00
Condition:   Acute Kidney Injury
Interventions:   Biological: SBI-101;   Device: Sham
Sponsor:   Sentien Biotechnologies, Inc.
Not yet recruiting - verified January 2017
Posted: Thursday, October 13, 2016 - 12:00
Condition:   Moderate to Severe Chronic Kidney Disease
Intervention:   Drug: Elixcyte
Sponsors:   UnicoCell Biomed CO. LTD;   A2 Healthcare Taiwan Corporation
Not yet recruiting - verified October 2016
Posted: Thursday, October 6, 2016 - 12:00
Conditions:   Type 2 Diabetes Mellitus;   Chronic Kidney Disease
Interventions:   Drug: Canagliflozin;   Drug: Placebo
Sponsors:   George Washington University;   Janssen Scientific Affairs, LLC
Recruiting - verified September 2016
Posted: Thursday, September 8, 2016 - 12:00
Condition:   Hemolytic Uremic Syndrome
Intervention:   Biological: Extra blood draw samples
Sponsor:   Assistance Publique Hopitaux De Marseille
Recruiting - verified September 2016
Posted: Thursday, June 2, 2016 - 12:00
Conditions:   End Stage Renal Disease (ESRD);   Vascular Access Complication
Intervention:   Biological: Adipose Derived Mesenchymal Stem Cells (AMSC)
Sponsor:   Mayo Clinic
Not yet recruiting - verified June 2016
Posted: Tuesday, March 22, 2016 - 12:00
Condition:   Chronic Kidney Disease
Interventions:   Drug: Group 2: Dasatinib;   Drug: Group 2: Quercetin
Sponsor:   Mayo Clinic
Recruiting - verified July 2016
Posted: Saturday, January 30, 2016 - 12:00
Conditions:   Glomerulosclerosis, Focal Segmental;   Renal Insufficiency, Chronic
Intervention:   Biological: Autologous Cell Transplantation
Sponsors:   Universidade Federal do Rio de Janeiro;   Ministry of Science and Technology, Brazil;   Ministry of Health, Brazil;   National Research Council, Brazil;   Rio de Janeiro State Research Supporting Foundation (FAPERJ)
Recruiting - verified February 2016
Posted: Tuesday, January 26, 2016 - 12:00
Condition:   Acute Kidney Injury
Interventions:   Drug: AST-120and pentoxyphylline (PTX);   Drug: pentoxyphylline (PTX)
Sponsors:   National Taiwan University Hospital;   National Taiwan University Hospital, Yun-Lin Branch;   National Taiwan University Hospital Hsin-Chu Branch;   China Medical University Hospital;   Taoyuan General Hospital;   Taipei Medical University Hospital;   Chang Gung Memorial Hospital
Recruiting - verified February 2016
Posted: Thursday, October 22, 2015 - 12:00
Condition:   Diabetic Kidney Disease
Interventions:   Biological: Mesenchymal Stromal Cells;   Other: Placebo
Sponsors:   Mario Negri Institute for Pharmacological Research;   Leiden University Medical Center;   NHS Blood and Transplant;   A.O. Ospedale Papa Giovanni XXIII;   Istituto Di Ricerche Farmacologiche Mario Negri;   Belfast Health and Social Care Trust;   National University of Ireland, Galway, Ireland;   University Hospital Birmingham
Not yet recruiting - verified October 2015
Posted: Tuesday, October 20, 2015 - 12:00
Condition:   Urinary Incontinence by Intrinsic Sphincter Deficiency
Intervention:   Other: Peri sphincter injection Autologous myofibers
Sponsor:   Assistance Publique - Hôpitaux de Paris
Not yet recruiting - verified October 2015